- Home
- NVGS vs DNA Comparison
NVGS vs DNA Comparison
Compare NVGS & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVGS
- DNA
- Stock Information
- Founded
- NVGS 1997
- DNA 2008
- Country
- NVGS United Kingdom
- DNA United States
- Employees
- NVGS N/A
- DNA N/A
- Industry
- NVGS Marine Transportation
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVGS Consumer Discretionary
- DNA Health Care
- Exchange
- NVGS Nasdaq
- DNA Nasdaq
- Market Cap
- NVGS 1.1B
- DNA 895.1M
- IPO Year
- NVGS N/A
- DNA N/A
- Fundamental
- Price
- NVGS $16.33
- DNA $12.19
- Analyst Decision
- NVGS Strong Buy
- DNA Strong Sell
- Analyst Count
- NVGS 3
- DNA 1
- Target Price
- NVGS $22.33
- DNA $9.00
- AVG Volume (30 Days)
- NVGS 337.8K
- DNA 1.6M
- Earning Date
- NVGS 11-04-2025
- DNA 11-07-2025
- Dividend Yield
- NVGS 1.23%
- DNA N/A
- EPS Growth
- NVGS 12.51
- DNA N/A
- EPS
- NVGS 1.26
- DNA N/A
- Revenue
- NVGS $566,889,000.00
- DNA $230,815,000.00
- Revenue This Year
- NVGS $1.63
- DNA N/A
- Revenue Next Year
- NVGS $2.78
- DNA $14.41
- P/E Ratio
- NVGS $12.98
- DNA N/A
- Revenue Growth
- NVGS 1.19
- DNA 25.21
- 52 Week Low
- NVGS $10.55
- DNA $5.00
- 52 Week High
- NVGS $17.53
- DNA $17.58
- Technical
- Relative Strength Index (RSI)
- NVGS 64.91
- DNA 43.24
- Support Level
- NVGS $14.74
- DNA $12.06
- Resistance Level
- NVGS $15.34
- DNA $13.77
- Average True Range (ATR)
- NVGS 0.34
- DNA 1.15
- MACD
- NVGS 0.20
- DNA -0.28
- Stochastic Oscillator
- NVGS 94.14
- DNA 2.93
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.